# CLOVIS ONCOLOGY INC (CLVSQ)

> Institutional ownership reported to the SEC as of Q3 2023, from Form 13F filings. Source: https://holderbook.com/stocks/CLVSQ/

- Reporting holders: 1
- Reported value: $11.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Coppell Advisory Solutions LLC](https://holderbook.com/funds/1848433-coppell-advisory-solutions-llc/) | $11.0K | 229 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2023 | 1 | $11.0K |
| Q1 2023 | 2 | $520.2K |
| Q4 2022 | 9 | $42.1K |
| Q3 2022 | 98 | $50.1M |
| Q2 2022 | 112 | $98.3M |
| Q1 2022 | 148 | $120.9M |
| Q4 2021 | 155 | $194.3M |
| Q3 2021 | 155 | $293.6M |
| Q2 2021 | 168 | $367.8M |
| Q1 2021 | 168 | $424.6M |
| Q4 2020 | 160 | $321.3M |
| Q3 2020 | 170 | $352.6M |